
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Clinical Breast Care Project, Windber Research Institute, Windber, Pennsylvania and Clinical Breast Care Project, Walter Reed Army Medical Center, Washington, District of Columbia
Requests for reprints: Rachel E. Ellsworth, Windber Research Institute, 600 Somerset Avenue, Windber, PA 15963. Phone: 814-467-9844; Fax: 814-467-6334. E-mail: rellswo{at}conemaugh.org
Axillary lymph node status is the most important prognostic factor in predicting disease outcome in women with breast cancer. A number of chromosomal aberrations in primary breast tumors have been correlated with lymph node status and clinical outcome, but chromosomal changes particular to metastatic lymph node tumors have not been well studied. DNA samples isolated from laser-microdissected primary breast and metastatic axillary lymph node tumors from 25 women with invasive breast cancer were amplified using 52 microsatellite markers defining 26 chromosomal regions commonly deleted in breast cancer. Levels and patterns of allelic imbalance (AI) within and between breast and lymph node tumors were assessed to identify chromosomal alterations unique to primary or metastatic tumors and to examine the timing of metastatic potential. The overall frequency of AI in primary breast tumors (0.24) was significantly greater (P < 0.001) than that in lymph node tumors (0.10), and congruent AI events were observed for <20% of informative markers. AI at chromosomes 11q23.3 and 17p13.3 occurred significantly more frequently (P < 0.05) in primary breast tumors alone; no chromosomal regions showed a significantly higher AI frequency in lymph nodes. Higher rates of AI in primary versus metastatic lymph node tumors suggest that acquisition of metastatic potential may be an early event in carcinogenesis, occurring before significant levels of AI accumulate in the primary tumor. In addition, patterns of AI were highly discordant between tumor types, suggesting that additional genetic alterations accumulated independently in the two cell populations.
This article has been cited by other articles:
![]() |
R. E. Ellsworth, D. L. Ellsworth, H. L. Patney, B. Deyarmin, J. A. Hooke, B. Love, and C. D. Shriver Genomic Alterations Associated with Early Stages of Breast Tumor Metastasis Ann. Surg. Oncol., July 1, 2008; 15(7): 1989 - 1995. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Becker, R. E. Ellsworth, B. Deyarmin, H. L. Patney, R. M. Jordan, J. A. Hooke, C. D. Shriver, and D. L. Ellsworth The Genomic Heritage of Lymph Node Metastases: Implications for Clinical Management of Patients with Breast Cancer Ann. Surg. Oncol., April 1, 2008; 15(4): 1056 - 1063. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Ellsworth, D. L. Ellsworth, B. Love, H. L. Patney, L. R. Hoffman, J. Kane, J. A. Hooke, and C. D. Shriver Correlation of Levels and Patterns of Genomic Instability With Histological Grading of DCIS Ann. Surg. Oncol., November 1, 2007; 14(11): 3070 - 3077. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Callaghan, T. E. Becker, D. L. Ellsworth, J. A. Hooke, R. E. Ellsworth, and C. D. Shriver Genomic Instability and the Development of Metastatic Lymph Node Tumors Ann. Surg. Oncol., November 1, 2007; 14(11): 3125 - 3132. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Yan, C. Venkataramu, A. Ibrahim, J. C. Liu, R. Z. Shen, N. M. Diaz, B. Centeno, F. Weber, Y.-W. Leu, C. L. Shapiro, et al. Mapping Geographic Zones of Cancer Risk with Epigenetic Biomarkers in Normal Breast Tissue. Clin. Cancer Res., November 15, 2006; 12(22): 6626 - 6636. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |